Vandetanib and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Vandetanib (vandetanib), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Paracetamol, and have Brain stem glioma.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Vandetanib. It is created by eHealthMe based on reports of 1,030 people who have side effects when taking Vandetanib from the FDA, and is updated regularly.

What is Vandetanib?

Vandetanib has active ingredients of vandetanib. eHealthMe is studying from 1,032 Vandetanib users. Check the latest studies of Vandetanib.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,354 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

On Aug, 09, 2026

1,030 people reported to have side effects when taking Vandetanib.
Among them, 62 people (6.02%) have Ocular hyperaemia.

Could Vandetanib cause Ocular hyperaemia?

Among these 62 people:

How long have people been on Vandetanib when they have Ocular hyperaemia? *

What is the gender of people who have Ocular hyperaemia when taking Vandetanib? *

female: 98.25 %
male: 1.75 %

What is the age of people who have Ocular hyperaemia when taking Vandetanib? *

What are other drugs people take besides Vandetanib? *

Paracetamol: 35 people, 56.45%
Afinitor: 24 people, 38.71%
Lansoprazole: 18 people, 29.03%
Dexamethasone: 18 people, 29.03%
Acetaminophen: 18 people, 29.03%
Ranitidine: 15 people, 24.19%
Everolimus: 12 people, 19.35%
Loperamide Hydrochloride: 3 people, 4.84%
Ranitidine Hydrochloride: 3 people, 4.84%
Nexium: 2 people, 3.23%

What are other side effects people have besides Ocular hyperaemia? *

Facial Paralysis (loss of function of face muscle): 61 people, 98.39%
Abdominal Distension: 59 people, 95.16%
Flatulence (flatus expelled through the anus): 59 people, 95.16%
Movement - Uncoordinated: 59 people, 95.16%
High Blood Cholesterol: 59 people, 95.16%
Hemiparesis (weakness on one side of the body): 59 people, 95.16%
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 59 people, 95.16%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 59 people, 95.16%
Electrocardiogram Qt Prolonged: 59 people, 95.16%
Alanine Aminotransferase Increased: 59 people, 95.16%

What are the existing conditions these people have? *

Brain Stem Glioma (cancerous glioma tumour in the brainstem): 59 people, 95.16%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 49 people, 79.03%
Diarrhea: 33 people, 53.23%
Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 2 people, 3.23%
Procedural Pain: 1 person, 1.61%
Glioma (a type of tumour that starts in the brain or spine): 1 person, 1.61%

* Approximation only. Some reports may have incomplete information.

Do you take Vandetanib and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vandetanib:

Vandetanib (1,032 reports)

Browse all side effects of Vandetanib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,354 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vandetanib (the active ingredients of Vandetanib) and Vandetanib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.